LIGAND PHARMACEUTICALS INC (LGNXZ) Net margin 2016–2025
LIGAND PHARMACEUTICALS INC (LGNXZ) net profit margin by fiscal year — reported net income divided by reported revenue.
46.4%FY2025 · since FY2016: -1.5% → 46.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 46.4% | +48.8 pp |
| FY2024 | -2.4% | -42.1 pp |
| FY2023 | 39.7% | +56.7 pp |
| FY2022 | -17.0% | -40.7 pp |
| FY2021 | 23.7% | +25.5 pp |
| FY2020 | -1.8% | -525.0 pp |
| FY2019 | 523.2% | +466.2 pp |
| FY2018 | 57.0% | +48.1 pp |
| FY2017 | 8.9% | +10.4 pp |
| FY2016 | -1.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice